Show simple item record

dc.contributor.authorKinner, SA
dc.contributor.authorSnow, K
dc.contributor.authorWirtz, AL
dc.contributor.authorAltice, FL
dc.contributor.authorBeyrer, C
dc.contributor.authorDolan, K
dc.date.accessioned2020-12-09T23:22:08Z
dc.date.available2020-12-09T23:22:08Z
dc.date.issued2018-03-01
dc.identifierpii: S1054-139X(17)30497-4
dc.identifier.citationKinner, S. A., Snow, K., Wirtz, A. L., Altice, F. L., Beyrer, C. & Dolan, K. (2018). Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review. JOURNAL OF ADOLESCENT HEALTH, 62 (3), pp.S18-S26. https://doi.org/10.1016/j.jadohealth.2017.09.030.
dc.identifier.issn1054-139X
dc.identifier.urihttp://hdl.handle.net/11343/253203
dc.description.abstractPURPOSE: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners. METHODS: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years). We used random effects meta-analysis to estimate the relative risk (RR) of each infection in AYAs versus older prisoners. RESULTS: Among 72 studies, there was marked heterogeneity in prevalence estimates among AYA prisoners for all infections: hepatitis B (.4%-25.2%), hepatitis C (.0%-70.6%), HIV (.0%-15.8%), and active tuberculosis (.0%-3.7%). The pooled prevalence of HIV (RR = .39, 95% confidence interval .29-.53, I2 = 79.2%) and hepatitis C (RR = .51, 95% confidence interval .33-.78, I2 = 97.8%) was lower in AYAs than in older prisoners. CONCLUSIONS: The prevalence of HIV and hepatitis C is lower in AYA prisoners than in older prisoners. Despite lower prevalence, acquisition begins early among incarcerated populations. There is an urgent need for targeted, age-appropriate prevention, treatment, and harm reduction measures in and beyond custodial settings to reduce the incidence of infection in these extremely vulnerable young people.
dc.languageEnglish
dc.publisherELSEVIER SCIENCE INC
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.titleAge-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review
dc.typeJournal Article
dc.identifier.doi10.1016/j.jadohealth.2017.09.030
melbourne.affiliation.departmentMelbourne School of Population and Global Health
melbourne.affiliation.departmentPaediatrics (RCH)
melbourne.source.titleJournal of Adolescent Health
melbourne.source.volume62
melbourne.source.issue3
melbourne.source.pagesS18-S26
melbourne.identifier.nhmrc1078168
dc.rights.licenseCC BY-NC-ND
melbourne.elementsid1307015
melbourne.contributor.authorSnow, Kathryn
melbourne.contributor.authorKinner, Stuart
melbourne.contributor.authorSnow, Kathryn Julia
dc.identifier.eissn1879-1972
melbourne.identifier.fundernameidNHMRC, 1078168
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record